Showing results (241-250 of 334) with videos related to
Sort By:
Pageof 34
European Urology|November 27, 2012
Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS)Fritz Schröder, Chris Bangma, Javier C Angulo, et al.Magnetic Resonance Imaging|June 18, 1999
In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathologyJ M García-Segura, M Sánchez-Chapado, C Ibarburen, et al.Scandinavian Journal of Urology|September 13, 2017
Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogramAna García-Tello, Helena Gimbernat, Cristina Redondo, et al.Cold Spring Harbor Perspectives in Medicine|September 11, 2019
Precise Immunodetection of PTEN Protein in Human NeoplasiaRafael Pulido, Janire Mingo, Ayman Gaafar, et al.The Journal of Urology|September 19, 2009
Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms)Javier C Angulo, Javier González, Nuria Rodríguez, et al.Semergen|October 12, 2023
[Demographic study of persons living with HIV (PLWH) newly diagnosed in the healthcare area of a tertiary-level hospital]A W Al-Hayani, A Cabello-Ubeda, M Ramírez Verdyguer, et al.Urology|August 23, 2021
Adjustable Transobturator Male System (ATOMS) Infection: Causative Organisms and Clinical ProfileJavier C Angulo, Keith Rourke, Fabian Queissert, et al.Actas Urologicas Espanolas|March 19, 2016
Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspectiveJ C Angulo, F Sánchez-Ballester, C Peral, et al.European Urology|March 30, 2013
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN)Philip Van Kerrebroeck, François Haab, Javier C Angulo, et al.International Journal of Molecular Sciences|January 8, 2023
Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate CancerMaría J Orea, Javier C Angulo, Ana González-Corpas, et al.Pageof 34